Clinical trials
Observational Leukemia trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 4 |
| Unknown status | 4 |
| Not yet recruiting | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 4 |
| Assistance Publique Hopitaux De Marseille | 2 |
| Centre Hospitalier Universitaire de Nīmes | 2 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
| Hospices Civils de Lyon | 1 |
| LEO Pharma | 1 |
| Nantes University Hospital | 1 |
| University Hospital, Bordeaux | 1 |
| University Hospital, Caen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 18 |
| Lymphoma | 8 |
| Myeloproliferative Disorders | 4 |
| Hematologic Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Bronchiolitis Obliterans Syndrome | 2 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
| Leukemia, Myeloid | 2 |
| Lung Neoplasms | 2 |
| Lymphoproliferative Disorders | 2 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.